Erratum to: NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022

In the June 2022 issue of JNCCN, the NCCN Guidelines Insights (J Natl Compr Canc Netw 2022;20[6]:622–634; doi: 10.6004/jnccn.2022.0031) was published with an error.

The last 2 sentences of the supporter statement were inadvertently omitted. The supporter statement should have read:

This activity is supported by educational grants from AstraZeneca; BeiGene; Exact Sciences; Gilead Sciences, Inc.; GlaxoSmithKline; Lantheus Medical Imaging Inc.; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Taiho Oncology, Inc. This activity is supported by an independent educational grant from Astellas. This activity is supported by an education grant from Astellas and Seagen Inc. This activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported through an Independent Medical Education grant from Merck & Co., Inc.

This has been corrected online. The editors and publisher apologize for the error.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 82 82 8
PDF Downloads 42 42 8
EPUB Downloads 0 0 0